TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.7        Europe Cardiometabolic Diseases market – By Country

2.           Europe Cardiometabolic Diseases Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Cardiometabolic Diseases Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

5.           Europe Cardiometabolic Diseases Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cardiometabolic Diseases

5.1.2        Innovation in Cardiometabolic Diseases Therapeutics

5.2         Market Restraints

5.2.1        Underdiagnosis of CVDs in Low- and Middle-Income Countries (LMICs)

5.3         Market Opportunities

5.3.1        Technological Advancements in CMD Diagnosis

5.4         Future Trends

5.4.1        Personalized Treatment for CMDs

5.5         Impact Analysis

6.           Europe Cardiometabolic Diseases Market – Regional Analysis

6.1         Europe Cardiometabolic Diseases Market Revenue Forecast And Analysis

7.           Europe Cardiometabolic Diseases Market Analysis – By Type

7.1         Overview

7.2         Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

7.3         Cardiovascular Disease (CVD)

7.3.1        Overview

7.3.2        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Hypertension

7.4.1        Overview

7.4.2        Hypertension: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Type 2 Diabetes

7.5.1        Overview

7.5.2        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Obesity

7.6.1        Overview

7.6.2        Obesity: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.           Europe Cardiometabolic Diseases Market Analysis – By Treatment

8.1         Overview

8.2         Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

8.3         ACE inhibitors

8.3.1        Overview

8.3.2        ACE: Cardiometabolic Diseases Inhibitors Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diuretics

8.4.1        Overview

8.4.2        Diuretics: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Glucophage

8.5.1        Overview

8.5.2        Glucophage: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        Others: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.           Europe Cardiometabolic Diseases Market Analysis – By Dosage

9.1         Overview

9.2         Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

9.3         Tablet

9.3.1        Overview

9.3.2        Tablet: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Injection

9.4.1        Overview

9.4.2        Injection: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

10.        Europe Cardiometabolic Diseases Market Analysis – By Route of Administration

10.1      Overview

10.2      Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Intravenous

10.4.1     Overview

10.4.2     Intravenous Market Revenue and Forecast to 2028 (US$ Mn)

11.        Europe Cardiometabolic Diseases Market Analysis – By End User

11.1      Overview

11.2      Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

11.3      Clinic

11.3.1     Overview

11.3.2     Clinic Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Hospital

11.4.1     Overview

11.4.2     Hospital Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Homecare Settings

11.5.1     Overview

11.5.2     Homecare Settings Market Revenue and Forecast to 2028 (US$ Mn)

12.        Europe Cardiometabolic Diseases Market Analysis – By Distribution Channel

12.1      Overview

12.2      Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

12.3      Hospital Pharmacy

12.3.1     Overview

12.3.2     Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.4      Retail Pharmacy

12.4.1     Overview

12.4.2     Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.5      Online Pharmacy

12.5.1     Overview

12.5.2     Online Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

13.        Europe Cardiometabolic Diseases Market – Geographic Analysis

13.1      Europe: Cardiometabolic Diseases Market Revenue and Forecasts to 2028

13.1.1     Overview

13.1.2     Europe: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.3     Europe: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.4     Europe: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.5     Europe: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.6     Europe: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.7     Europe: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.8     Europe: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.9     Europe Cardiometabolic Diseases Market Revenue and Forecasts to 2028, By Country (%)

13.1.9.1       Germany Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.9.1.1       Germany: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.10  Germany: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.11  Germany: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.12  Germany: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.13  Germany: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.14  Germany: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.15  Germany: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.15.1    UK Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.15.1.1    UK; Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.16  UK: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.17  UK: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.18  UK: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.19  UK: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.20  UK: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.21  UK: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.21.1    France Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.21.1.1    France: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.22  France: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.23  France: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.24  France: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.25  France: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.26  France: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.27  France: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.27.1    Italy Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.27.1.1    Italy: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.28  Italy: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.29  Italy: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.30  Italy: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.31  Italy: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.32  Italy: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.33  Italy: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.33.1    Spain Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.33.1.1    Spain Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.34  Spain: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.35  Spain: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.36  Spain: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.37  Spain: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.38  Spain: Cardiometabolic Diseases Market, by End User, Revenue and Forecast to 2028 (USD Million)

13.1.39  Spain: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

13.1.39.1    Rest of Europe Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.39.1.1    Rest of Europe: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

13.1.40  Rest of Europe: Cardiometabolic Diseases Market Revenue, by Type, Revenue and Forecast to 2028 (USD Million)

13.1.41  Rest of Europe: Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

13.1.42  Rest of Europe: Cardiometabolic Diseases Market, by Dosage, Revenue and Forecast to 2028 (USD Million)

13.1.43  Rest of Europe: Cardiometabolic Diseases Market, by Route of Administration, Revenue and Forecast to 2028 (USD Million)

13.1.44  Rest of Europe: Cardiometabolic Diseases Market, by End User Revenue and Forecast to 2028 (USD Million)

13.1.45  Rest of Europe: Cardiometabolic Diseases Market, Distribution Channel, Revenue and Forecast to 2028 (USD Million)

14.        Impact of COVID-19 Pandemic on Europe Cardiometabolic Diseases Market

14.1      Europe: Impact Assessment of COVID-19 Pandemic

15.        Europe Cardiometabolic Diseases Market – Industry Landscape

15.1      Overview

15.2      Growth Strategies in the Cardiometabolic Diseases Market (%)

15.3      Organic Developments

15.3.1     Overview

15.4      Inorganic Developments

15.4.1     Overview

16.        Company Profiles

16.1      Eli Lilly and Company.

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Products and Services

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2      Bayer AG

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Products and Services

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3      Novartis AG

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Products and Services

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4      Boehringer Ingelheim International GmbH

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Products and Services

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5      Novo Nordisk A/S

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Products and Services

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6      AstraZeneca

16.6.1     Key Facts

16.6.2     Business Description

16.6.3     Products and Services

16.6.4     Financial Overview

16.6.5     SWOT Analysis

16.6.6     Key Developments

16.7      Alnylam Pharmaceuticals, Inc.

16.7.1     Key Facts

16.7.2     Business Description

16.7.3     Products and Services

16.7.4     Financial Overview

16.7.5     SWOT Analysis

16.7.6     Key Developments

16.8      Kowa Company, Ltd.

16.8.1     Key Facts

16.8.2     Business Description

16.8.3     Products and Services

16.8.4     Financial Overview

16.8.5     SWOT Analysis

16.8.6     Key Developments

17.        Appendix

17.1      About The Insight Partners

17.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Europe Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 3.             Europe Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 4.             Europe Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 5.             Europe Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 6.             Europe Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 7.             Germany Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Germany Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 9.             Germany Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 11.          Germany Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 12.          Germany Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 13.          UK Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          UK Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 15.          UK Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 16.          UK Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 17.          UK Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 18.          UK Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 19.          France Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          France Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 21.          France Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 22.          France Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 23.          France Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 24.          France Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 25.          Italy Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 26.          Italy Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 27.          Italy Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 28.          Italy Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 29.          Italy Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 30.          Italy Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 31.          Spain Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 32.          Spain Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 33.          Spain Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 34.          Spain Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 35.          Spain Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 36.          Spain Cardiometabolic Diseases Market, by Distribution Channel, – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Europe Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 38.          Rest of Europe Cardiometabolic Diseases Market, by Treatment– Revenue and Forecast to 2028 (USD Million)

Table 39.          Rest of Europe Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 40.          Rest of Europe Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million

Table 41.          Rest of Europe Cardiometabolic Diseases Market, by End User – Revenue and Forecast to 2028 (USD Million

Table 42.          Rest of Europe Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 43.          Organic Developments in the Cardiometabolic Diseases Market

Table 44.          Inorganic Developments in the Cardiometabolic Diseases Market

Table 45.          Glossary of Terms, Europe Cardiometabolic Diseases Market

LIST OF FIGURES

Figure 1.           Europe Cardiometabolic Diseases Market Segmentation

Figure 2.           Europe Cardiometabolic Diseases Market Overview

Figure 3.           Cardiovascular Disease (CVD) Segment Held Largest Share of Type of Europe Cardiometabolic Diseases Market

Figure 4.           Europe Cardiometabolic Diseases Market – Leading Country Markets (US$ Million)

Figure 5.           Europe Cardiometabolic Diseases Market, Industry Landscape

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Cardiometabolic Diseases Market Impact Analysis of Drivers and Restraints

Figure 8.           Europe Cardiometabolic Diseases Market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

Figure 10.        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Hypertension: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Obesity: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

Figure 15.        ACE inhibitors: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        Diuretics: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Glucophage: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Others: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

Figure 20.        Tablet: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Injection: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

Figure 23.        Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Intravenous Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

Figure 26.        Clinic Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        Hospital Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Homecare Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

Figure 30.        Hospital Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Retail Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Online Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        Europe: Cardiometabolic Diseases Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 34.        Europe Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.        Europe Cardiometabolic Diseases Market Revenue and Forecasts to 2028, By Country (%)

Figure 36.        Germany: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 37.        UK: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38.        France: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39.        Italy: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        Spain Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41.        Rest of Europe: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42.        Impact of COVID-19 Pandemic on Europe Cardiometabolic Diseases Market

Figure 43.        Growth Strategies in the Cardiometabolic Diseases Market (%)